LAUREN BLACKBURN: Open Payments
NPI 1720769151 · OXFORD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$151 in 8 payments from 4 companies in 2025. Trend: 2023 $174 · 2024 $200 · 2025 $151
Food & beverage: $151
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $75 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: VRAYLAR, CAPLYTA, Qelbree, COBENFY.
Industry payments across MS — which companies pay providers there.
